Pharmacology 2017 #4A (Chapter 32, 36, and 37) Flashcards
Which laboratory test would give the most accurate evidence of a diabetic patient’s treatment compliance and glucose management over the past few months?
- Serum albumin
- Fasting serum glucose level
- 2-hour postprandial blood glucose
- Glycosylated hemoglobin (HbA1C)
Glycosylated hemoglobin (HbA1C)
HbA1c indicates glucose concentrations over the past 3 to 4 months and thus demonstrates patient compliance and illness management over time. The serum albumin test helps to determine the level of natural protein in blood. The fasting serum glucose test helps to assess whether the patient has elevated blood glucose concentrations. A 2-hour postprandial blood glucose test determines the amount of glucose in the blood after a meal.
A patient newly diagnosed with type 2 diabetes mellitus has been ordered insulin glargine. What information is essential for the nurse to teach this patient?
- “This medication has a duration of action of 24 hours.”
- “This medication should be mixed with the regular insulin each morning.”
- “This medication is very short-acting. You must be sure you eat after injecting it.”
- “This medication is very expensive, but you will be receiving it only a short time.”
“This medication has a duration of action of 24 hours.”
Insulin glargine has a duration of action of 24 hours with no peaks, mimicking the natural, basal insulin secretion of the pancreas. This medication cannot be mixed with other insulins and is not a short-acting insulin. The patient may need to receive this medication for a long time.
The nurse is teaching a patient who has asthma about the frequency of inhalation of salmeterol. Which statement by the patient indicates effective learning?
- “I will inhale it once a day upon waking.”
- “I will inhale it once a day before bedtime.”
- “I will inhale it twice a day at my convenience.”
- “I will inhale it twice a day approximately 12 hours apart.”
“I will inhale it twice a day approximately 12 hours apart.”
The action of salmeterol starts in a patient with asthma within 30 to 48 minutes after inhalation; the peak effect occurs in 3 to 4 hours, and the duration of action is 12 hours. Thus, the bronchodilator inhalation dose for adults and children older than 12 years is one puff twice daily, morning and evening, approximately 12 hours apart. The drug will not exhibit the correct therapeutic effect if used once a day or at the convenience of the patient.
The nurse is teaching a patient who has been prescribed repaglinide. Which information will the nurse include in the teaching plan?
- “This medication will not cause hypoglycemia.”
- “You will need to be sure you eat as soon as you take this medication.”
- “You do not have to worry about side effects when taking this medication.”
- “When taking this medication, use aspirin rather than acetaminophen for pain relief.”
“You will need to be sure you eat as soon as you take this medication.”
Repaglinide is short acting. The drug’s very fast onset of action allows patients to take the drug with meals and skip a dose when they skip a meal. Hypoglycemia is a side effect of this medication, and there are many other possible side effects of this medication. The effects of repaglinide are enhanced when taken with aspirin and other nonsteroidal antiinflammatory drugs, which may result in increased hypoglycemia.
A patient comes to the emergency department with urticaria after contact with shrubs. Which type of drug should the nurse expect to be included in the treatment plan?
- Antitussive
- Expectorant
- Decongestant
- Antihistamine
Antihistamine
Urticaria after contact with shrubs indicates an allergic reaction. All allergic reactions are mediated by histamines. Therefore, an antihistamine should be included in the treatment plan. Antitussives are medications that help to suppress the cough reflex. Expectorants help in coughing up excessive mucus and clearing the airway. Decongestants usually relieve congestion of the upper and lower respiratory tract.
A patient is prescribed inhaled corticosteroids. Why should the nurse ask the patient to rinse the mouth after each dose?
- To relieve the patient’s dry mouth
- To minimize the chance of nasal congestion
- To reduce the risk of sore throat and infection
- To prevent the development of oral candidiasis
To prevent the development of oral candidiasis
It is recommended that patients rinse their mouth immediately after use of the inhaler or nebulizer dosage forms of corticosteroids. It helps to prevent overgrowth of oral fungi and subsequent development of oral candidiasis (thrush). Dry mouth, nasal congestion, and sore throat are not side effects of corticosteroid inhaler use.
A patient who reports nasal congestion is prescribed naphazoline, 2 drops in each nostril, every 6 hours, for 5 days. The patient reports increased nasal congestion after 10 days. On assessment the nurse learns that the patient had increased the drug frequency to every 3 hours for 10 days. What should the nurse interpret from this information?
- The patient has developed an allergic reaction.
- The patient has developed rebound congestion.
- The patient has developed paradoxical reaction.
- The patient has experienced a side effect of the drug.
The patient has developed rebound congestion.
Nasal decongestants should be used as directed, in the prescribed dose, and for the prescribed time period. Frequent, long-term use or overdose may lead to rebound congestion. When the patient stops the drug, the symptoms may worsen, so the patient may overdose to get relief from symptoms. Allergic reactions rarely occur with decongestants, and rebound congestion is not a symptom of allergic reaction. Paradoxical reactions are related to antihistamine use in older adults and pediatric patients. Side effects of decongestants include nervousness, insomnia, palpitations, and tremor.
A patient taking an oral theophylline drug is due for the next dose and has a blood pressure of 100/50 mm Hg and a heart rate of 110 beats/min. The patient is irritable. What is the nurse’s best action?
- Administer oxygen at 2 L per minute via nasal cannula.
- Continue to monitor the patient and give the medication.
- Hold the next dose of theophylline and assess the patient.
- Call the health care provider to request an increased dose.
Hold the next dose of theophylline and assess the patient.
The patient is displaying possible adverse reactions to theophylline such as tachycardia and irritability, and the blood level should be assessed before another dose of the medication is given. These symptoms may also be related to hypoxia. The nurse should assess for hypoxia before administering oxygen. The nurse should hold the medication and evaluate the cause for these symptoms. Until the serum theophylline level is known, an increased dose is not indicated.
A patient receiving inhaled ipratropium therapy visits the clinic for a follow-up. Which complaint should the nurse anticipate from the patient?
- Insomnia
- Dry mouth
- Anginal pain
- Vascular headache
Dry mouth
The most commonly reported adverse effects of ipratropium therapy are caused by the anticholinergic effects of the drug and include dry mouth or throat, nasal congestion, heart palpitations, gastrointestinal distress, urinary retention, increased intraocular pressure, headache, coughing, and anxiety. Insomnia, anginal pain, and vascular headache are the adverse effects of alpha-adrenergic agonists.
Which anticholinergic effect is seen in a patient who takes brompheniramine?
- Frequent urination
- Dry mouth
- Blue-green vision
- Excessive watering of eyes
Dry mouth
Antihistamines such as brompheniramine cause reduced salivary flow, leading to dry mouth. Anticholinergic effects of antihistamines, such as blurred vision, are common, not colored vision. They may also cause urinary retention, not frequent urination. Antihistamines help relieve excessive watering of eyes.
A patient is prescribed albuterol. The nurse is explaining the most common route of administration of albuterol to the patient. Which route should the nurse discuss?
- Inhalation
- Intravenous
- Subcutaneous
- Intramuscular
Inhalation
The most preferred route of administration of albuterol is inhalation. Oral routes also are sometimes used. Intravenous, subcutaneous, and intramuscular routes are not suitable for administering albuterol.
For what will the nurse assess in a patient who is prescribed metformin for treatment of type 2 diabetes?
- Headache
- Weight gain
- Renal function
- Cholesterol level
Renal function
Because metformin is excreted by the kidneys, it is necessary to assess the patient’s renal function. If the patient’s kidneys are not able to excrete the drug, it will accumulate in the patient’s system, thereby causing lactic acidosis. Headaches are not caused by metformin. One of the adverse effects of metformin is weight loss, not weight gain. Cholesterol levels may be high in some diabetic patients but can be treated with medications and lifestyle changes.
A patient is prescribed oral albuterol to treat bronchitis. What instruction should the nurse give to the patient to prevent gastrointestinal (GI) upset?
- “Take the prescribed medication with food.”
- “Increase fluid intake up to 2500 mL a day.”
- “Avoid sleeping with the head in an elevated position.”
- “Take the prescribed medication on an empty stomach.”
“Take the prescribed medication with food.”
Albuterol is a beta agonist. Beta agonists can cause GI. Therefore, the nurse should instruct the patient to take the medication with food to avoid GI upset. Although food may slightly decrease absorption of the drug, it has the benefit of minimizing GI upset. An increase in fluid intake is helpful for maintaining hydration but not for minimizing GI upset. Keeping the head elevated is comfortable but does not help to minimize GI upset.
The nurse is caring for a child who has been prescribed an inhaler for asthma control. The child is having difficulty using the inhaler. What should the nurse do?
- Teach the child to use a spacer.
- Tell the parent to hold the inhaler for the child.
- Ask the health care provider to switch to oral medications.
- Tell the parent that young children should not use inhalers.
Teach the child to use a spacer.
If a child is unable to use the inhaler, the medication will be trapped in the mouth. Using a spacer helps the medication to be deposited to the lungs.
Which medications inhibit the enzyme alpha-glucosidase in the treatment of type 2 diabetes mellitus? Select all that apply.
- Miglitol
- Glipizide
- Acarbose
- Nateglinide
- Pioglitazone
Miglitol & Acarbose
Alpha-glucosidase inhibitors are a class of antidiabetic drugs used to inhibit the alpha-glucosidase enzyme. Miglitol and acarbose are drugs that inhibit the alpha-glucosidase enzyme. Glipizide is a sulfonylurea that stimulates the release of insulin. Nateglinide is a glinide that increases insulin secretion. Pioglitazone is a thiazolidinedione that decreases insulin resistance by enhancing the sensitivity of insulin receptors.
A patient who is obese is newly diagnosed with type 2 diabetes and is instructed to make dietary changes and perform aerobic exercise daily. The patient asks for insulin therapy for prompt management of diabetes. However, the patient is prescribed oral medications for lowering glucose levels. What is the reason for delaying insulin therapy?
- Insulin therapy is initiated when other methods have failed.
- Insulin therapy is not generally prescribed for obese patients.
- Insulin therapy is ineffective without initial oral drug therapy.
- Insulin therapy may cause congestive heart failure to develop.
Insulin therapy is initiated when other methods have failed.
For patients with Type 2 diabetes mellitus, insulin therapy is usually reserved for when other treatment methods are unsuccessful. It is more important to start oral drug therapy and initiate lifestyle changes as an initial treatment for diabetes mellitus management. Insulin is prescribed for obese patients if the initial drug therapy and lifestyle changes are ineffective in lowering glucose levels. Insulin therapy is used for diabetic management and is used along with oral drug therapy. Insulin therapy does not cause congestive heart failure in patients. It is more a concern in patients who take pioglitazone.